Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: A consensus guideline

BJU International

Volumn 116, Issue 4, 2015, Pages 509-525

  Rees, Jon ^a   Abrahams, Mark ^b   Doble, Andrew ^b   Cooper, Alison ^c  

^a Backwell and Nailsea Medical Group   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c Prostate Cancer UK ^*  (United Kingdom)

Author keywords

chronic bacterial prostatitis; chronic prostatitis with chronic pelvic pain syndrome; guidelines; prostatitis

Indexed keywords

ALFUZOSIN; AMITRIPTYLINE; AZITHROMYCIN; CELECOXIB; CERNITIN; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; DOXAZOSIN; DOXYCYCLINE; DULOXETINE; DUTASTERIDE; FINASTERIDE; GABAPENTIN; IBUPROFEN; LEVOFLOXACIN; PLACEBO; PREGABALIN; PROSTATE SPECIFIC ANTIGEN; QUINOLONE DERIVATIVE; ROFECOXIB; SILODOSIN; TAMSULOSIN; TERAZOSIN; TETRACYCLINE; TRIMETHOPRIM;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; ATAXIA; BACTERIAL CLEARANCE; BACTERIAL INFECTION; BACTERIUM CULTURE; BLURRED VISION; CHLAMYDIASIS; CHRONIC BACTERIAL PROSTATITIS; CHRONIC PROSTATITIS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL FEATURE; COGNITIVE THERAPY; CONSTIPATION; CONTROLLED STUDY; DELPHI STUDY; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG EFFICACY; DYSPEPSIA; EDEMA; ELECTROACUPUNCTURE; EVENING DOSAGE; FOLLOW UP; HEADACHE; HUMAN; INFECTION CONTROL; INSOMNIA; LOWER URINARY TRACT SYMPTOM; MALE; MONOTHERAPY; MORNING DOSAGE; NAUSEA; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PAIN SEVERITY; PATIENT HEALTH QUESTIONNAIRE 9; PELVIS PAIN SYNDROME; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PHYTOTHERAPY; PRIORITY JOURNAL; PROSTATITIS; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; RECURRENT DISEASE; SCORING SYSTEM; SCREENING TEST; SEXUAL DYSFUNCTION; SYMPTOM; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; URINE RETENTION; XEROSTOMIA; CHRONIC PAIN; CONSENSUS; PELVIC PAIN;

CHRONIC PAIN; CONSENSUS; HUMANS; MALE; PELVIC PAIN; PROSTATITIS;

EID: 84941189872     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13101     Document Type: Article

References (112)

1. Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE,. Epidemiology of prostatitis. Int J Antimicrob Agents 2008; 31 (Suppl. 1): S85-90
2. Pavone-Macaluso M,. Chronic prostatitis syndrome: a common, but poorly understood condition. Part I. EAU-EBU Update Ser 2007; 5: 1-15
3. Nyberg LM, Krieger JN, Nickel JC,. National Institutes of Health Classification of Chronic Prostatitis. In, Nickel JC, ed, Textbook of Prostatitis. London: CRC Press, 1999: 28
4. McNaughton Collins M, Pontari MA, O'Leary MP, et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med 2001; 16: 656-62
5. University of Oxford Centre for Evidence Based Medicine. OCEBM Levels of Evidence System. Available at: http://www.cebm.net/index.aspx?o=5653. Accessed June 2014
6. Hsu CC, Sandford BA,. The delphi technique: making sense of consensus. Pract Assess Res Eval 2007; 12: 1-8. Available at: http://pareonline.net/getvn.asp?v=12&n=10. Accessed March 2015
7. Mahal BA, Cohen JM, Allsop SA, et al. The role of phenotyping in chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 2011; 12: 297-303
8. Zhao Z, Zhang J, He J, Zeng G,. Clinical utility of the UPOINT phenotype system in Chinese males with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a prospective study. PLoS One 2013; 8: e52044
9. Grabe M, Bjerklund-Johansen TE, Botto H, et al. Guidelines on Urological Infections, 2013. European Association of Urology. Available at: http://uroweb.org/wp-content/uploads/18-Urological-infections-LR.pdf. Accessed March 2015
10. Hetrick DC, Ciol MA, Rothman I, Turner JA, Frest M, Berger RE,. Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case-control study. J Urol 2003; 170: 828-31
11. NHS Choices. Map of Medicine. Prostatitis-Primary Care, January 2014. Available at: http://healthguides.mapofmedicine.com/choices/pdf/prostatitis1.pdf. Accessed June 2014
12. Shoskes DA, Berger R, Elmi A, Landis JR, Propert KJ, Zeitlin S,. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J Urol 2008; 179: 556-60
13. Vicari E, La Vignera S, Arcoria D, et al. High frequency of chronic bacterial and non-inflammatory prostatitis in infertile patients with prostatitis syndrome plus irritable bowel syndrome. PLoS One 2011; 6: e18647
14. Wagenlehner FM, van Till JW, Magri V, et al. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol 2013; 63: 953-9
15. Clemens JQ, Brown SO, Kozloff L, Calhoun EA,. Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. J Urol 2006; 175: 963-7
16. Vicari E, Calogero AE, Condorelli RA, Vicari LO, La Vignera S,. Male accessory gland infection frequency in infertile patients with chronic microbial prostatitis and irritable bowel syndrome: transrectal ultrasound examination helps to understand the links. J Androl 2012; 33: 404-11
17. Bartoletti R, Cai T, Mondaini N, et al. Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study. J Urol 2007; 178: 2411-5
18. Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, Gao SY, Calhoun EA,. Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community. J Urol 2005; 174: 2319-22
19. Daniels NA, Link CL, Barry MJ, McKinlay JB,. Association between past urinary tract infections and current symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome. J Natl Med Assoc 2007; 99: 509-16
20. Nickel JC, Shoskes D, Wang Y, et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol 2006; 176: 119-24
21. Nickel JC,. Classification and diagnosis of prostatitis: a gold standard? Andrologia 2003; 35: 160-7
22. Anderson RU, Wise D, Sawyer T, Chan CA,. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol 2006; 176: 1534-9
23. Davis SN, Binik YM, Amsel R, Carrier S,. Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs "UPOINT" to yes. J Urol 2013; 189: 146-51
24. Gonen M, Kalkan M, Cenker A, Ozkardes H,. Prevalence of premature ejaculation in Turkish men with chronic pelvic pain syndrome. J Androl 2005; 26: 601-3
25. Mehta A, Stember DS, O'Brien K, Mulhall JP,. Defining the aetiology of erectile dysfunction in men with chronic pelvic pain syndrome. Andrology 2013; 1: 483-6
26. Muller A, Mulhall JP,. Sexual dysfunction in the patient with prostatitis. Curr Opin Urol 2005; 15: 404-9
27. Sadeghi-Nejad H, Seftel A,. Sexual dysfunction and prostatitis. Curr Urol Rep 2006; 7: 479-84
28. Shoskes DA, Landis JR, Wang Y, Nickel JC, Zeitlin SI, Nadler R,. Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004; 172: 542-7
29. Smith KB, Pukall CF, Tripp DA, Nickel JC,. Sexual and relationship functioning in men with chronic prostatitis/chronic pelvic pain syndrome and their partners. Arch Sex Behav 2007; 36: 301-11
30. Wagenlehner F, Pilatz A, Linn T, et al. Prostatitis and andrological implications. Minerva Urol Nefrol 2013; 65: 117-23
31. Lee SW, Liong ML, Yuen KH, et al. Adverse impact of sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome. Urology 2008; 71: 79-84
32. Magri V, Perletti G, Montanari E, Marras E, Chiaffarino F, Parazzini F,. Chronic prostatitis and erectile dysfunction: results from a cross-sectional study. Arch Ital Urol Androl 2008; 80: 172-5
33. Trinchieri A, Magri V, Cariani L, et al. Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. Arch Ital Urol Androl 2007; 79: 67-70
34. Liang CZ, Zhang XJ, Hao ZY, Shi HQ, Wang KX,. Prevalence of sexual dysfunction in Chinese men with chronic prostatitis. BJU Int 2004; 93: 568-70
35. Davis SN, Morin M, Binik YM, Khalife S, Carrier S,. Use of pelvic floor ultrasound to assess pelvic floor muscle function in Urological Chronic Pelvic Pain Syndrome in men. J Sex Med 2011; 8: 3173-80
36. Liang CZ, Hao ZY, Li HJ, et al. Prevalence of premature ejaculation and its correlation with chronic prostatitis in Chinese men. Urology 2010; 76: 962-6
37. Samplaski MK, Li J, Shoskes DA,. Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2011; 78: 653-8
38. NHS Choices. Map of Medicine. Prostatitis-Secondary Care, January 2014. Available at: http://healthguides.mapofmedicine.com/choices/pdf/prostatitis2.pdf. Accessed June 2014
39. Engeler DS, Baranowski AP, Elneil S, et al. Guidelines on Chronic Pelvic Pain. European Association of Urology, 2012. Available at: http://www.uroweb.org/gls/pdf/24-Chronic-Pelvic-Pain-LR%20II.pdf. Accessed June 2014
40. Lazaro N,. Sexually Transmitted Infections in Primary Care. Royal College of General Practitioners, 2013. Available at: http://www.rcgp.org.uk/clinical-andresearch/clinicalresources/~/media/Files/CIRC/RCGP-Sexually-Transmitted-Infections-in-Primary-Care-2013.ashx. Accessed June 2014
41. Clemens JQ, Brown SO, Calhoun EA,. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol 2008; 180: 1378-82
42. Anderson RU, Orenberg EK, Chan CA, Morey A, Flores V,. Psychometric profiles and hypothalamic-pituitary-adrenal axis function in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 2008; 179: 956-60
43. Ku JH, Jeon YS, Kim ME, Lee NK, Park YH,. Psychological problems in young men with chronic prostatitis-like symptoms. Scand J Urol Nephrol 2002; 36: 296-301
44. Hedelin H,. The chronic prostatitis/chronic pelvic pain syndrome and pain catastrophizing: a vicious combination. Scand J Urol Nephrol 2012; 46: 273-8
45. Murphy AB, Macejko A, Taylor A, Nadler RB,. Chronic prostatitis: management strategies. Drugs 2009; 69: 71-84
46. Weidner W, Anderson RU,. Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation. Int J Antimicrob Agents 2008; 31 (Suppl. 1): S91-5
47. Magri V, Cariani L, Bonamore R, Restelli A, Garlaschi MC, Trinchieri A,. Microscopic and microbiological findings for evaluation of chronic prostatitis. Arch Ital Urol Androl 2005; 77: 135-8
48. Nickel JC, Downey J, Clark J, et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 2003; 62: 614-7
49. Burford D, Kirby M, Austoker J,. Prostate Cancer Risk Management Programme information for primary care; PSA testing in asymptomatic men. Evidence document, 2010. Available at: http://www.cancerscreening.nhs.uk/prostate/pcrmp02.pdf. Accessed July 2014
50. Shoskes DA, Nickel JC, Rackley RR, Pontari MA,. Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis 2009; 12: 177-83
51. Shoskes DA, Nickel JC, Kattan MW,. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 2010; 75: 1249-53
52. Hu JC, Link CL, McNaughton-Collins M, Barry MJ, McKinlay JB,. The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey. J Gen Intern Med 2007; 22: 1532-7
53. Alexander RB, Propert KJ, Schaeffer AJ, et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004; 141: 581-9
54. Chen Y, Wu X, Liu J, Tang W, Zhao T, Zhang J,. Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized trial. World J Urol 2011; 29: 381-5
55. Nickel JC, Narayan P, McKay J, Doyle C,. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 2004; 171: 1594-7
56. Mehik A, Alas P, Nickel JC, Sarpola A, Helstrom PJ,. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003; 62: 425-9
57. Nickel JC, Krieger JN, McNaughton-Collins M, et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 2008; 359: 2663-73
58. Evliyaoʇlu Y, Burgut R,. Lower urinary tract symptoms, pain and quality of life assessment in chronic non-bacterial prostatitis patients treated with alpha-blocking agent doxazosin; versus placebo. Int Urol Nephrol 2002; 34: 351-6
59. Tuʇcu V, Taşçi AI, Fazlioʇlu A, et al. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur Urol 2007; 51: 1113-8
60. Cheah PY, Liong ML, Yuen KH, et al. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome. Urology 2004; 64: 881-6
61. Gül O, Eroʇlu M, Ozok U,. Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. Int Urol Nephrol 2001; 32: 433-6
62. Nickel JC, O'Leary MP, Lepor H, et al. Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study. J Urol 2011; 186: 125-31
63. Anothaisintawee T, Attia J, Nickel JC, et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 2011; 305: 78-86
64. Cohen JM, Fagin AP, Hariton E, et al. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis. PLoS One 2012; 7: e41941
65. Bundrick W, Heron SP, Ray P, et al. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urology 2003; 62: 537-41
66. Skerk V, Schönwald S, Krhen I, et al. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents 2003; 21: 457-62
67. Zhang ZC, Jin FS, Liu DM, Shen ZJ, Sun YH, Guo YL,. Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients. Asian J Androl 2012; 14: 870-4
68. Skerk V, Krhen I, Lisic M, et al. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004; 24: 188-91
69. Skerk V, Schönwald S, Krhen I, et al. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2002; 14: 384-9
70. Magri V, Montanari E, Skerk V, et al. Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. Asian J Androl 2011; 13: 819-27
71. Magri V, Marras E, Skerk V, et al. Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination. Andrologia 2010; 42: 366-75
72. Zhou Z, Hong L, Shen X, et al. Detection of nanobacteria infection in type III prostatitis. Urology 2008; 71: 1091-5
73. Ye ZQ, Lan RZ, Yang WM, Yao LF, Yu X,. Tamsulosin treatment of chronic non-bacterial prostatitis. J Int Med Res 2008; 36: 244-52
74. Kulovac B, Aganovic D, Prcic A, Hadziosmanovic O,. Management of chronic nonbacterial prostatitis/chronic pelvic pain syndrome. Bosn J Basic Med Sci 2007; 7: 245-9
75. Nickel JC, Pontari M, Moon T, et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003; 169: 1401-5
76. Zhao WP, Zhang ZG, Li XD, et al. Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA). Braz J Med Biol Res 2009; 42: 963-7
77. Lee CB, Ha US, Lee SJ, Kim SW, Cho YH,. Preliminary experience with a terpene mixture versus ibuprofen for treatment of category III chronic prostatitis/chronic pelvic pain syndrome. World J Urol 2006; 24: 55-60
78. Pontari MA, Krieger JN, Litwin MS, et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med 2010; 170: 1586-93
79. Kaplan SA, Volpe MA, Te AE,. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol 2004; 171: 284-8
80. Leskinen M, Lukkarinen O, Marttila T,. Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study. Urology 1999; 53: 502-5
81. Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI,. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004; 93: 991-5
82. Nickel JC, Roehrborn C, Montorsi F, Wilson TH, Rittmaster RS,. Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study. J Urol 2011; 186: 1313-8
83. National Clinical Guideline Centre. The Management of lower urinary tract symptoms in men. Methods, Evidence & Guidance. NCGC, 2010. Available at: http://www.nice.org.uk/guidance/cg97/resources/cg97-lower-urinary-tract-symptoms-fullguideline3. Accessed July 2014
84. Jeong CW, Lim DJ, Son H, Lee SE, Jeong H,. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination. Urol Int 2008; 80: 157-61
85. Magri V, Trinchieri A, Pozzi G, et al. Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis. Int J Antimicrob Agents 2007; 29: 549-56
86. Shoskes DA, Hakim L, Ghoniem G, Jackson CL,. Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol 2003; 169: 1406-10
87. Clemens JQ, Nadler RB, Schaeffer AJ, Belani J, Albaugh J, Bushman W,. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology 2000; 56: 951-5
88. Cornel EB, van Haarst EP, Schaarsberg RW, Geels J,. The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III. Eur Urol 2005; 47: 607-11
89. He W, Chen M, Zu X, Li Y, Ning K, Qi L,. Chronic prostatitis presenting with dysfunctional voiding and effects of pelvic floor biofeedback treatment. BJU Int 2010; 105: 975-7
90. Anderson RU, Wise D, Sawyer T, Chan C,. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol 2005; 174: 155-60
91. Anderson RU, Wise D, Sawyer T, Glowe P, Orenberg EK,. 6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training. J Urol 2011; 185: 1294-9
92. Sikiru L, Shmaila H, Muhammed SA,. Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo-control randomized trial. Int Braz J Urol 2008; 34: 708-14
93. Chen R, Nickel JC,. Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2003; 61: 1156-9
94. Honjo H, Kamoi K, Naya Y, et al. Effects of acupuncture for chronic pelvic pain syndrome with intrapelvic venous congestion: preliminary results. Int J Urol 2004; 11: 607-12
95. Tugcu V, Tas S, Eren G, Bedirhan B, Karadag S, Tasci A,. Effectiveness of acupuncture in patients with category IIIB chronic pelvic pain syndrome: a report of 97 patients. Pain Med 2010; 11: 518-23
96. Lee SW, Liong ML, Yuen KH, et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. Am J Med 2008; 121: 79 e1-7
97. Lee SH, Lee BC,. Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial. Urology 2009; 73: 1036-41
98. Lee SH, Lee BC,. Use of acupuncture as a treatment method for chronic prostatitis/chronic pelvic pain syndromes. Curr Urol Rep 2011; 12: 288-96
99. Elist J,. Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study. Urology 2006; 67: 60-3
100. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J,. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999; 54: 960-3
101. Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Brahler E, Weidner W,. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol 2009; 56: 544-51
102. Morgia G, Mucciardi G, Gali A, et al. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study. Urol Int 2010; 84: 400-6
103. Cai T, Mazzoli S, Bechi A, et al. Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study. Int J Antimicrob Agents 2009; 33: 549-53
104. Chiang PH, Chiang CP,. Therapeutic effect of transurethral needle ablation in non-bacterial prostatitis: chronic pelvic pain syndrome type IIIa. Int J Urol 2004; 11: 97-102
105. Kastner C, Hochreiter W, Huidobro C, Cabezas J, Miller P,. Cooled transurethral microwave thermotherapy for intractable chronic prostatitis-results of a pilot study after 1 year. Urology 2004; 64: 1149-54
106. Mishra VC, Browne J, Emberton M,. Role of repeated prostatic massage in chronic prostatitis: a systematic review of the literature. Urology 2008; 72: 731-5
107. Ateya A, Fayez A, Hani R, Zohdy W, Gabbar MA, Shamloul R,. Evaluation of prostatic massage in treatment of chronic prostatitis. Urology 2006; 67: 674-8
108. Kabay S, Kabay SC, Yucel M, Ozden H,. Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a Sham-Controlled Comparative Study. Urol Int 2009; 83: 33-8
109. Joint Formulary Committee. British National Formulary (BNF) 67. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, Pharmaceutical Press, 2014
110. Aboumarzouk OM, Nelson RL,. Pregabalin for chronic prostatitis. Cochrane Database Syst Rev 2012; 8: CD009063
111. National Institute for Health and Care Excellence. Neuropathic pain-pharmacological management: The pharmacological management of neuropathic pain in adults in non-specialist settings. NICE CG 173. NICE, 2013. Available at: http://www.nice.org.uk/guidance/cg173/resources/guidance-neuropathic-pain-pharmacological-management-pdf. Accessed July 2014
112. Prostate Cancer UK. Understanding the PSA test: A guide for men concerned about prostate cancer. 2014. Available at: http://prostatecanceruk.org/media/41628/2782-understanding-psa-test.pdf. Accessed April 2015.